Tomorrow Investor

SAGA Metals Acquires Strategic Titanium Assets from Rio Tinto in Quebec

SAGA Metals Acquires Titanium Assets in Quebec – Key Move | GlobeNewsWire

VANCOUVER, British Columbia, March 26, 2026 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discoveries, is pleased to announce that it has completed the acquisition (the “Acquisition”) from Rio Tinto Exploration Canada Inc (“RTEC”) of a 100% interest in the Garneau project (the “Garneau Project”) comprised of 120 claims covering 6,450.54 hectares located near Havre-Sainte-Pierre, Quebec. RTEC is a Canadian subsidiary of the Rio Tinto Group (“Rio Tinto”) (NYSE: RIO, LSE: RIO, ASX: RIO).

This excerpt is quoted from the original release. Read the full announcement on GlobeNewsWire.

Brief Summary

SAGA Metals Corp. has successfully completed the acquisition of titanium assets from Rio Tinto, enhancing its position in the critical minerals sector. This strategic move signifies SAGA’s commitment to securing valuable resources that support sustainable development.

  • 100% acquisition of Garneau Project.
  • Covers 6,450.54 hectares near Havre-Sainte-Pierre, Quebec.
  • Focus on critical mineral discoveries.
  • Strengthens SAGA’s future operations.

Why it matters: This acquisition not only expands SAGA’s resource base but also positions the company favorably within the competitive landscape of critical minerals, essential for future technological advancements.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by GlobeNewsWire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.